P53 Patient Preferences for Multiple Myeloma Treatment: A Stated Preference Survey Using Discrete Choice Experiment and Swing Weighting

Patient preferences have become an important focus for inclusion in drug development and evaluation. Understanding patient preferences is especially valuable in Multiple Myeloma (MM), where the rapid development of treatments with diverging benefit-risk profiles raises uncertainty about what matters most to patients. This study aimed to investigate which treatment attributes (side-effects, symptoms, efficacy outcomes, uncertainties) are most important to MM patients.